NCOA4 was originally described as a coactivator of multiple nuclear hormone receptors, and is closely related to the tumorigenesis and progression in ovarian cancer, prostate cancer, breast cancer and pancreatic cancer. This evidence concerns the gene NR0B1 and prostate carcinoma.